Maple-Brown Abbott’s NiSource NI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $75.1M | Sell |
1,872,810
-438,533
| -19% | -$16.9M | 5.12% | 12 |
|
|
2024
Q4 | $85M | Sell |
2,311,343
-756,680
| -25% | -$27.2M | 10.36% | 5 |
|
|
2024
Q3 | $106M | Sell |
3,068,023
-241,200
| -7% | -$7.7M | 10.55% | 2 |
|
|
2024
Q2 | $95.3M | Sell |
3,309,223
-133,290
| -4% | -$3.76M | 10.05% | 2 |
|
|
2024
Q1 | $95.2M | Buy |
3,442,513
+656,060
| +24% | +$17.2M | 9.74% | 3 |
|
|
2023
Q4 | $74M | Buy |
2,786,453
+568,980
| +26% | +$14.6M | 7.53% | 8 |
|
|
2023
Q3 | $54.7M | Sell |
2,217,473
-53,190
| -2% | -$1.44M | 6.28% | 8 |
|
|
2023
Q2 | $62.1M | Buy |
2,270,663
+5,740
| +0.3% | +$159K | 6.9% | 7 |
|
|
2023
Q1 | $63.3M | Buy |
2,264,923
+17,650
| +0.8% | +$483K | 7.2% | 7 |
|
|
2022
Q4 | $61.6M | Buy |
2,247,273
+101,270
| +5% | +$2.66M | 7.2% | 8 |
|
|
2022
Q3 | $54.1M | Sell |
2,146,003
-229,880
| -10% | -$6.77M | 6.96% | 9 |
|
|
2022
Q2 | $70.1M | Sell |
2,375,883
-1,629,154
| -41% | -$49.3M | 6.97% | 8 |
|
|
2022
Q1 | $127M | Sell |
4,005,037
-1,256,790
| -24% | -$36.5M | 8.9% | 7 |
|
|
2021
Q4 | $145M | Sell |
5,261,827
-1,935,661
| -27% | -$49.2M | 9.69% | 5 |
|
|
2021
Q3 | $174M | Sell |
7,197,488
-62,110
| -0.9% | -$1.55M | 9.69% | 5 |
|
|
2021
Q2 | $178M | Buy |
7,259,598
+382,810
| +6% | +$9.74M | 9.6% | 5 |
|
|
2021
Q1 | $166M | Buy |
6,876,788
+962,950
| +16% | +$21.7M | 9.3% | 5 |
|
|
2020
Q4 | $136M | Buy |
5,913,838
+815,200
| +16% | +$19.1M | 8.76% | 3 |
|
|
2020
Q3 | $112M | Sell |
5,098,638
-519,710
| -9% | -$12.1M | 8.81% | 4 |
|
|
2020
Q2 | $128M | Buy |
5,618,348
+821,010
| +17% | +$19.8M | 9.97% | 2 |
|
|
2020
Q1 | $120M | Sell |
4,797,338
-942,490
| -16% | -$26.1M | 10.72% | 1 |
|
|
2019
Q4 | $160M | Buy |
5,739,828
+950,440
| +20% | +$26.1M | 11.94% | 3 |
|
|
2019
Q3 | $143M | Buy |
4,789,388
+765,910
| +19% | +$22.5M | 11.32% | 4 |
|
|
2019
Q2 | $116M | Buy |
4,023,478
+270,040
| +7% | +$7.61M | 9.81% | 4 |
|
|
2019
Q1 | $104M | Buy |
3,753,438
+108,970
| +3% | +$2.94M | 8.72% | 3 |
|
|
2018
Q4 | $92.4M | Buy |
3,644,468
+447,050
| +14% | +$11.5M | 8.28% | 3 |
|
|
2018
Q3 | $79.7M | Sell |
3,197,418
-175,400
| -5% | -$4.64M | 6.35% | 8 |
|
|
2018
Q2 | $88.6M | Sell |
3,372,818
-264,300
| -7% | -$6.48M | 6.92% | 6 |
|
|
2018
Q1 | $87M | Buy |
3,637,118
+185,900
| +5% | +$4.4M | 7.36% | 4 |
|
|
2017
Q4 | $88.6M | Buy |
3,451,218
+930,314
| +37% | +$24.7M | 7.43% | 4 |
|
|
2017
Q3 | $64.5M | Sell |
2,520,904
-255,800
| -9% | -$6.73M | 6.41% | 8 |
|
|
2017
Q2 | $70.4M | Buy |
2,776,704
+1,135,300
| +69% | +$28.3M | 7.25% | 6 |
|
|
2017
Q1 | $39M | Buy |
1,641,404
+648,846
| +65% | +$14.8M | 4.78% | 10 |
|
|
2016
Q4 | $22M | Buy |
+992,558
| New | +$22.1M | 3.09% | 15 |
|
|
2016
Q1 | – | Sell |
-300,465
| Closed | -$5.86M | – | 20 |
|
|
2015
Q4 | $5.86M | Sell |
300,465
-193,135
| -39% | -$3.71M | 1.99% | 18 |
|
|
2015
Q3 | $9.16M | Buy |
+493,600
| New | +$8.44M | 3.46% | 13 |
|
Other funds holding NI
Maple-Brown Abbott's NI Position: Q1 2025 in Review
Maple-Brown Abbott reduced its NiSource (NI) stake by 19% in Q1 2025, selling an estimated $16.9M and leaving 1,872,810 shares worth $75.1M. The position accounts for 5.12% of the portfolio, ranked #12.
Maple-Brown Abbott first reported a position in NI in Q3 2015 and has held it in 36 quarters since. The position peaked at $178M in Q2 2021. 795 funds tracked by Wall St. Rank hold NI as of Q1 2025.
- Maple-Brown Abbott held 1,872,810 shares of NiSource worth $75.1M as of Q1 2025.
- Maple-Brown Abbott sold 438,533 NiSource shares in Q1 2025, an estimated $16.9M.
- NiSource made up 5.12% of Maple-Brown Abbott's portfolio in Q1 2025, its #12 holding.
- Maple-Brown Abbott first reported a position in NiSource in Q3 2015 and has held it in 36 quarters since.
- Maple-Brown Abbott's NiSource position peaked at $178M in Q2 2021.
- 795 funds tracked by Wall St. Rank held NiSource as of Q1 2025.
Based on Maple-Brown Abbott's 13F filing for Q1 2025, filed 13 May 2025.